Waystar Holding Corp., a healthcare payment software provider, announced it will report its financial results for the third quarter ending September 30, 2026, after market close on November 2, 2026. The company will hold a conference call at 4:30 p.m. Eastern Time the same day to discuss the results, which will be available via live webcast on its investor relations website. Waystar serves over 30,000 clients and processes a significant volume of healthcare payments in the U.S., making this report important for investors tracking the healthcare tech sector.
Waystar's upcoming Q3 2026 financial results are announced ahead of its November 2 report. For readers following the health sector, here is Pluang's market snapshot as of Oct 15, 2026 03:02 WIB: out of 150 priced US health-sector stocks, 90 rose and 60 fell. Notable movers include GeneDx Holdings Corp (WGS) at USD 68.25 with a 5.06% increase and 100% buy order activity, Bristol-Myers Squibb Co (BMY) at USD 59.29 with a 4.62% rise and 98% buy orders, and SELLAS Life Sciences Group Inc. (SLS) at USD 11.84 with a 4.59% decline and 100% buy orders.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
